Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients
Authors:
- Valéria MeszlényiVMValéria Meszlényi
- Roland PataiRPRoland Patai
- Tamás F. PolgárTPTamás F. Polgár
- Bernát NógrádiBNBernát Nógrádi
- Laura KörmöczyLKLaura Körmöczy
- Rebeka KristófRKRebeka Kristóf
- Krisztina SpisákKSKrisztina Spisák
- Kornélia TripolszkiKTKornélia Tripolszki
- Márta SzéllMSMárta Széll
- Izabella ObálIOIzabella Obál
- József I. EngelhardtJEJózsef I. Engelhardt
- László SiklósLSLászló Siklós
Open Access
- 3 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (15) , 5566
Abstract
Previously, we demonstrated increased calcium levels and synaptic vesicle densities in the motor axon terminals (MATs) of sporadic amyotrophic lateral sclerosis (ALS) patients. Such alterations could be conferred to mice with an intraperitoneal injection of sera from these patients or with purified immunoglobulin G. Later, we confirmed the presence of similar alterations in the superoxide dismutase 1 G93A transgenic mouse strain model of familial ALS. These consistent observations suggested that calcium plays a central role in the pathomechanism of ALS. This may be further reinforced by completing a similar analytical study of the MATs of ALS patients with identified mutations. However, due to the low yield of muscle biopsy samples containing MATs, and the low incidence of ALS patients with the identified mutations, these examinations are not technically feasible. Alternatively, a passive transfer of sera from ALS patients with known mutations was used, and the MATs of the inoculated mice were tested for alterations in their calcium homeostasis and synaptic activity. Patients with 11 different ALS-related mutations participated in the study. Intraperitoneal injection of sera from these patients on two consecutive days resulted in elevated intracellular calcium levels and increased vesicle densities in the MATs of mice, which is comparable to the effect of the passive transfer from sporadic patients. Our results support the idea that the pathomechanism underlying the identical manifestation of the disease with or without identified mutations is based on a common final pathway, in which increasing calcium levels play a central role.Keywords
Funding Information
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00034, GINOP-2.3.3.-15-2016-00001)
- Emberi Eroforrások Minisztériuma (EMMI: 11136-2/2019/FIRFIN, NTP-NFTÖ-18-B-208)
This publication has 85 references indexed in Scilit:
- Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytesCell Calcium, 2013
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomaticallyAmyotrophic Lateral Sclerosis, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Oxidative stress in ALS: Key role in motor neuron injury and therapeutic targetFree Radical Biology and Medicine, 2010
- Calcium signaling and neurodegenerative diseasesTrends in Molecular Medicine, 2009
- A review of recent advances in stereology for quantifying neural structureJournal of Neurocytology, 1992
- Glutamate neurotoxicity in cortical cell culture is calcium dependentNeuroscience Letters, 1985
- The role of calcium in the toxicity of the myocardiumJournal of Molecular Histology, 1981
- Two rapid and simple methods used for the removal of resins from 1.0 μm thick epoxy sectionsJournal of Microscopy, 1978